Lineage Cell Therapeutics, Inc. · AMEX:LCTX

NEAL C. BRADSHER reported a 24.50% stake in Lineage Cell Therapeutics, Inc. (Schedule 13D/A)

Event Jan 27, 2025 · Filed Jan 28, 2025

NEAL C. BRADSHER reported a 24.50% stake in Lineage Cell Therapeutics, Inc., 57,848,357 shares, with active intent on Jan 27, 2025. Filed Jan 28, 2025 (Schedule 13D/A).

Stake
24.50%
Shares
57,848,357
Intent
Active
What changed
Stake changed
Filed together
3 holders

The filing in full

HolderStakeShares
BROADWOOD PARTNERS, L.P.24.30%57,455,729
BROADWOOD CAPITAL, INC.24.30%57,455,729
NEAL C. BRADSHER24.50%57,848,357

Source

View original at SEC

Related